Correlation of liver enzyme levels and infection with HCMV after HSCT in China

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-09000314

Enrollment

Unknown

Registered

2009-01-11

Start date

2006-09-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recipients after hematopoietic stem cell transplantation (HSCT)

Interventions

Uninfection group:No

Infection group:No

Eligibility

Sex/Gender

Male

Age

2 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who were followed regularly for more than 6 months after receiving transplantation in our hospital and who provided written informed consent were enrolled in the study.

Exclusion criteria

Exclusion criteria: Clinical conditions that to be expected alive shorter than 6 months; previous HBV, HCV, or HDV infections, and other liver diseases.

Design outcomes

Primary

Measure	Time frame
Infection rate;	—

Secondary

Measure	Time frame
Liver enzyme level;	—

Countries

China

Contacts

Public ContactWeihang Ma

maweihang@zju.edu.cn+86 0 15858224023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026